We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Thermo Scientific Expands Bio HPLC Column Portfolio
Product News

Thermo Scientific Expands Bio HPLC Column Portfolio

Thermo Scientific Expands Bio HPLC Column Portfolio
Product News

Thermo Scientific Expands Bio HPLC Column Portfolio

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Thermo Scientific Expands Bio HPLC Column Portfolio"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Thermo Fisher Scientific Inc. has expanded its portfolio of Thermo Scientific Accucore columns with a range of columns for biomolecule separations.

Available in analytical, micro and nano formats, the new Accucore™ 150-C18 and Accucore 150-C4 columns are designed to improve protein and peptide assay robustness by enhancing peak capacity and run times at moderate operating pressures.

Thermo Fisher introduced the new Accucore HPLC and nano LC columns at HPLC 2012 in Anaheim, Calif. within Thermo Scientific booth 121.

The 150 angstrom pore diameter of the solid core particles is designed to provide the optimal combination of retention time and resolution for peptides and proteins.

The Accucore 150-C18 has been further optimized for biomolecules and protein digests through bonding of C18 ligands onto the porous outer layer of the particles.

The low hydrophobicity C4 ligand used in the Accucore 150-C4 column enables fast protein separations.

“In the pharmaceutical industry, biological drugs continue to make gains compared to conventional drugs, with a significant rise anticipated between 2010 to 2016*,” said Darren Thomas, business director, Chromatography Consumables Solutions, Thermo Fisher. “We believe that the Accucore family of columns will accelerate time to market for these large-molecule based drugs.”

Accucore columns are based on Core Enhanced Technology™, featuring solid core particles engineered to an average size distribution of 1.12. A result is high-resolution separations with backpressures significantly lower than those of UHPLC.

Advanced bonding technology produces excellent peak shapes through high bonding coverage and minimized secondary interactions.

The automated packing processes produce uniform, tightly-packed columns that are robust and reproducible.

For more information about Accucore HPLC columns, please visit: www.thermoscientific.com/accucore150.